Figure 3.
Kaplan–Meir curves for all high-risk clinical phenotypes, separated between revascularization and medical therapy, and comparing these interventions between the ASTRAL and Salford cohorts. (A) Heart failure. (B) Rapid progressor. (C) Coronary artery disease and diabetes mellitus. (D) Advanced chronic kidney disease. (E) Refractory hypertension.
